» Articles » PMID: 29434537

How Can a Ketogenic Diet Improve Motor Function?

Overview
Specialty Molecular Biology
Date 2018 Feb 14
PMID 29434537
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

A ketogenic diet (KD) is a normocaloric diet composed by high fat (80-90%), low carbohydrate, and low protein consumption that induces fasting-like effects. KD increases ketone body (KBs) production and its concentration in the blood, providing the brain an alternative energy supply that enhances oxidative mitochondrial metabolism. In addition to its profound impact on neuro-metabolism and bioenergetics, the neuroprotective effect of specific polyunsaturated fatty acids and KBs involves pleiotropic mechanisms, such as the modulation of neuronal membrane excitability, inflammation, or reactive oxygen species production. KD is a therapy that has been used for almost a century to treat medically intractable epilepsy and has been increasingly explored in a number of neurological diseases. Motor function has also been shown to be improved by KD and/or medium-chain triglyceride diets in rodent models of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and spinal cord injury. These studies have proposed that KD may induce a modification in synaptic morphology and function, involving ionic channels, glutamatergic transmission, or synaptic vesicular cycling machinery. However, little is understood about the molecular mechanisms underlying the impact of KD on motor function and the perspectives of its use to acquire the neuromuscular effects. The aim of this review is to explore the conditions through which KD might improve motor function. First, we will describe the main consequences of KD exposure in tissues involved in motor function. Second, we will report and discuss the relevance of KD in pre-clinical and clinical trials in the major diseases presenting motor dysfunction.

Citing Articles

Lauric acid with or without levodopa ameliorates Parkinsonism in genetically modified model of Drosophila melanogaster via the oxidative-inflammatory-apoptotic pathway.

Idowu O, Dosumu O, Boboye A, Oremosu A, Mohammed A Brain Behav. 2024; 14(9):e70001.

PMID: 39245995 PMC: 11381577. DOI: 10.1002/brb3.70001.


Ketogenic therapy towards precision medicine for brain diseases.

Liu Y, Fan L, Yang H, Wang D, Liu R, Shan T Front Nutr. 2024; 11:1266690.

PMID: 38450235 PMC: 10915067. DOI: 10.3389/fnut.2024.1266690.


Ketosis Suppression and Ageing (KetoSAge): The Effects of Suppressing Ketosis in Long Term Keto-Adapted Non-Athletic Females.

Cooper I, Kyriakidou Y, Edwards K, Petagine L, Seyfried T, Duraj T Int J Mol Sci. 2023; 24(21).

PMID: 37958602 PMC: 10650498. DOI: 10.3390/ijms242115621.


The Role of a Ketogenic Diet in the Treatment of Dementia in Type 2 Diabetes Mellitus.

Bai L, Zhou Y, Zhang J, Ma J Nutrients. 2023; 15(8).

PMID: 37111190 PMC: 10142932. DOI: 10.3390/nu15081971.


Bibliometric analysis of global research profile on ketogenic diet therapies in neurological diseases: Beneficial diet therapies deserve more attention.

Wang Y, Zhang J, Zhang Y, Yao J Front Endocrinol (Lausanne). 2023; 13:1066785.

PMID: 36686482 PMC: 9846225. DOI: 10.3389/fendo.2022.1066785.


References
1.
Ahola-Erkkila S, Carroll C, Peltola-Mjosund K, Tulkki V, Mattila I, Seppanen-Laakso T . Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum Mol Genet. 2010; 19(10):1974-84. DOI: 10.1093/hmg/ddq076. View

2.
Cheng B, Yang X, An L, Gao B, Liu X, Liu S . Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease. Brain Res. 2009; 1286:25-31. DOI: 10.1016/j.brainres.2009.06.060. View

3.
Su H, Fan W, Coskun P, Vesa J, Gold J, Jiang Y . Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome. Neurosci Lett. 2009; 487(2):129-33. PMC: 2888840. DOI: 10.1016/j.neulet.2009.06.079. View

4.
Bixel M, Hamprecht B . Generation of ketone bodies from leucine by cultured astroglial cells. J Neurochem. 1995; 65(6):2450-61. DOI: 10.1046/j.1471-4159.1995.65062450.x. View

5.
Lutas A, Yellen G . The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 2012; 36(1):32-40. PMC: 3534786. DOI: 10.1016/j.tins.2012.11.005. View